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Summary 
In murine T  cell development, early thymocytes that productively rearrange the T cell receptor 
(TCR)  [3 locus are selected to continue maturation, before TCRcx expression, by means of a 
pre-TCRet-  (pT~-)  TCR[3  heterodimer (pre-TCR).  The aim  of this study was  to identify 
equivalent stages  in human  thymocyte development. We  show here that variable-diversity- 
joining region TCR[3 rearrangement and the expression of full-length TCR[3 transcripts have 
been initiated in some immature thymocytes at the TCRoJ[3- CD4+CD8 -  stage, and become 
common in a downstream subset ofTCRot/[3- CD4+CD8 + thymocytes that is highly enriched 
in large cycling cells. TCR[3 chain expression was hardly detected in TCR~x/[3- CD4+CD8 -  thy- 
mocytes, whereas cytoplasmic TCR[3 chain was found in virtually all TCRc~/13- CD4+CD8 + 
blasts. In addition, a TCR[5 complex distinct from the mature TCRoJ[3 heterodimer was im- 
munoprecipitated only from the latter subset,  cDNA derived from TCRod[3-  CD4+CD8 + 
blasts allowed us to identify and clone the gene encoding the human pTo~ chain, and to exam- 
ine its  expression at different stages  of thymocyte development. Our results show that high 
pTot  transcription  occurs  only  in  CD4+CD8 -  and  CD4+CD8 +  TCRot/[3-  thymocytes, 
whereas it is weaker in earlier and later stages of development. Based on these results,  we pro- 
pose that the transition from TCRot/[3- CD4+CD8 -  to TCRod[3- CD4+CD8 + thymocytes 
represents a critical developmental stage at which the successful  expression of TCR[3 promotes 
the clonal expansion and further maturation of human thymocytes, independent of TCRoc 
D 
uring thymocyte development in normal mice, rear- 
rangement and expression of the TCR[3  chain gene 
precedes that of the a  chain (1). The first TCR[3 gene rear- 
rangements are detectable in a subset of CD4-CD8-  dou- 
ble negative (DN) 1 thymocytes that express IL-2Rcx (CD25) 
(2, 3).  However, most rearrangements are out-of-frame at 
this stage  (4). In contrast, the V-D-J rearrangements of the 
immediate  progeny of these  cells  (i.e.,  CD25-  DN  thy- 
mocytes)  (3)  are  predominantly  in-frame,  indicating  that 
cells within the CD25- DN population have been selected 
on the basis of productively rearranged [3 chain genes (4). 
The  CD25 +  to  CD25-  transition  is  accompanied  by  a 
strong  cellular proliferation, which  is  consistent with  the 
fact that CD25- DN thymocytes include a high proportion 
1Abbreviations used in this paper: DN, double negative; DP, double posi- 
tive, pTcx, pre-TCRoq RAG-l, recombinase activating  gene 1; RT, re- 
verse transcriptase; SP, single positive. 
The first two authors contributed  equally to this work. 
of large cycling cells (5). Prohferating CD25- blasts rapidly 
acquire  (or express already)  low levels of CD4  and  CD8 
and, therefore, represent cells in transit to the CD4+CD8 + 
double positive (DP) stage (6, 7). At this stage, proliferation 
comes to an abrupt halt, TCRot/[3 is expressed for the first 
time, and DP thymocytes are subsequently selected to de- 
velop into mature CD4 + or CD8 + single positive (SP) thy- 
mocytes (5, 8, 9). Therefore, the transition from CD25 + to 
CD25-  DN thymocytes appears to be the critical stage  at 
which  cells  with  productive  [3  chain  expression  gain  a 
selective  advantage  to  mature  further,  independently  of 
TCRe~ (3, 4). 
Evidence supporting such a regulatory role of the TCR[3 
protein in early T  cell development was originally obtained 
in  SCID  mice,  and  later  confirmed  in  rearrangement 
(RAG-1  or RAG-2)-deficient mice,  and  in  mice with  a 
mutated TCR[3  gene. Both the severe drop in total thy- 
mocyte numbers and the blockade at the CD25 + DN stage 
observed in these animals were fully restored upon intro- 
duction of a productively rearranged TCR[3 transgene (9- 
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the  ot  chain,  is  suflficient  for  driving  CD25 §  DN  thy- 
mocytes to the DP stage, and results in the expansion of the 
DP thymocyte pool. In contrast, TCR.ot expression appears 
irrelevant to these processes,  but its role seems to be con- 
fined to further differentiation ofDP thymocytes to the SP 
stage (11). 
The biochemical form of the  TCRJ3+/e~ -  complex in- 
volved in early thymocyte development has recently been 
resolved by the identification on murine pre-T cell lines of 
a disulphide-linked  heterodimer  (referred  to as pre-TCR) 
composed  of TCRI3  and  a  novel  33-kD  transmembrane 
glycoprotein termed pre-TCRot  (pTot)  chain or gp33 (12, 
13).  This  complex has  also  been  found on large  DP  thy- 
mocytes  from  TCP,.ot -/-  mice  (12).  Recent  analysis  of 
pTot  gene-deficient  mice  (14)  provided formal proof that 
expression  of the pre-TCR  is physiologically reqmred  for 
the  transition  of CD25 §  DN  T  cell  precursors,  through 
rapidly dividing CD25-  DN  cells,  into small CD4+CD8 + 
thymocytes (4,  5,  15). 
Evidence for an equivalent pre-TCR complex in human 
thymocyte  development  is  still  lacking.  Furthermore,  al- 
though TCR[3 rearrangement also precedes that of TCIL0t 
in humans  (16),  no direct experimental  evidence has been 
provided  that  resolves  the  timing  of TCR[3  and  TCl~ot 
gene  expression  during  the  development  of human  thy- 
mocytes. In the present study we have approached this is- 
sue by direct examination  of the  transcriptional  activation 
of both  TCRJ3  and TC1kci genes  in  individual  subsets  of 
TCR-negative  thymocytes  representative  of the  earliest 
human intrathymic stages  (17).  This analysis allowed us to 
identify a novel subset of  large-sized TClko~/[3- CD4+CD8 + 
cycling thymocytes  that  express  a  functionally  rearranged 
TCRJ3 locus but lack TCRot gene expression. Using eDNA 
derived  from these  cells  we  could  identify  and  clone  the 
human  pTot  eDNA.  Comparison  of the  developmental 
regulation of pT0t,  TCR[3,  TCRel,  and RAG-1  gene ex- 
pression  provided a  clear picture  of the  maturauonal  pro- 
gression of early human intrathymic stages and led us to iden- 
tiff/the  transition  from CD4+CD8 -  to large  CD4+CD8 + 
thymocytes as  a  key  control point  in  early  human  T  cell 
development. 
Materials  and Methods 
Cell Samples.  Fetal  thymus,  hver,  and  bone  marrow  tassue 
were obtained from 18-22-wk fetuses after legal termination of 
pregnancy. Umbilical cord blood samples were collected imme- 
diately  after  delivery.  Adult  bone  marrow  was  obtained  from 
puncture of the lllac crest of healthy donors. Peripheral  blood was 
obtained from pauents subjected to chemotherapy and treatment 
with  G-CSF.  CD34 + cells (>99% punty upon reanalysis) were 
isolated  from  the  indicated  sources  by  Ficoll-Hypaque  (Ny- 
comed, Oslo, Norway) centrifugauon (18) followed by immuno- 
magnetic sorting with anti-CD34-coupled magnetic beads  (Dy- 
nabeads; Dynal Corp., Oslo, Norway). 
Postnatal thymus samples were removed during corrective car- 
diac surgery of pauents aged  1 mo to 3 yr.  Thymocyte suspen- 
sions were depleted of small-  and medium-sized TCRot/13 + DP 
thymocytes  by  centrifugation  on  stepwlse  Percoll  (Pharmacla 
LKB, Uppsala,  Sweden)  density gradients  as previously described 
(19).  Large  thymocytes recovered from the  1.068  density  layer 
were further depleted (>99% purity) of or/J3 and ~//~ mature T 
cells, as well as of B, NK, and myeloid cells, by two rounds of de- 
pletion with anti-CD3- and anti-CD19-coated  magnetic beads 
(Dynal), and with anti-CD56 (Leu-19; Becton Dickinson & Co., 
San Jose,  CA) and anti-CDllb  (MO1; Coulter Corp., Hialeah, 
FL)  mAbs indirectly  coupled  to  sheep  anti-mouse  lgG-coated 
magnetic beads (Dynal).  CD4+CD8 "~ thymocytes were magneti- 
cally sorted from the remaining pool with anti-CD8-coated mag- 
netic beads  (Dynal).  CD4+CD8  -  thymocytes were then isolated 
from the CD8-depleted pool by treatment with ann-CD'4-coated 
magnetic beads (Dynal). The remaining CD4-CD8- thymocytes 
were finally sorted into the CD34+CD 1- and CD34+CD 1  + sub- 
sets by treatment with an anti-CDla  (Nal/34)  nLAb (20) indi- 
rectly coupled to magnetic beads  (Dynal),  as described  (21). Ma- 
ture TCRot/[3 + SP cells were isolated  from CDl-depleted large 
thymocytes by treatment with antl-CD3-coated magnetic beads. 
Conventional  TClko~/J3 +  CD4+CD8 §  small thymocytes  (re- 
ferred to as DP) were isolated from the 1.09 Percoll density layer 
by magnetic sorting with anti-CDla. 
Flow Cytometry Analysis.  Directly  labeled  mAbs  against  the 
following antigens  were used: CD4 (Leu3a-PE),  CD34 (HPCA- 
2-PE), and CD8  (Leu2a-FITC) from Becton Dickinson & Co." 
CDla  (T6-R.D1  and  T6-FITC),  and  CD71  (Tg-FITC)  from 
Coulter Corp.; CD28 (CD28-FITC) from Serotec Ltd., Oxford, 
UK; and CD44 (CD44-FITC) from Caltag Laboratories  (South 
San Francisco,  CA). Unlabeled mAb against CD8{3 (2ST8-5H7, 
kindly provided by Dr. E.L.  Remherz, Dana-Farber Cancer In- 
stitute,  Boston, MA) (22), as well as mAb recognizing monomor- 
phic determinants  of TCRot/[3  (BMA031,  generously provided 
by Dr. ik.  Kurrle,  Behnngwerke AG, Marburg, Germany) were 
used in combination with goat anti-mouse FITC- or PE-coupled 
F(ab)'2  Ig  (Southern  Biotechnology Associates,  Inc.,  Birming- 
ham, AL). Isotype-matched irrelevant  mAbs (Caltag Laboratories) 
were  used  as  negative  controls.  For  detection  of cytoplasmic 
TCR[3,  cells were  treated  with  0.5%  saponm  (Sigma  Chemical 
Co., St.  Louis,  MO), incubated with the antl-TCR~ chain [3F1 
mAb  (generously provided  by  Dr.  M  Brenner,  Brigham  and 
Women's Hospital,  Boston, MA) (23), and labeled with PE-cou- 
pied goat anti-mouse IgG1 (Southern Biotechnology Associates, 
Inc.).  Stained  cells were analyzed in an Epics XL flow cytometer 
(Coulter Corp.) as previously described  (21). Cell cycle analyses 
were performed by flow cytometry in cells treated  with  0.05% 
digatonm,  washed,  and stained  with 50 ~tg/ml of propldmm io- 
dide (both from Sigma Chemical Co.). 
TCR~ Gene Rearrangement Analysis.  TCR[3  gene  rearrange- 
ments  were  analyzed  by  using  a  mo&ficauon of the  genomlc 
DNA-PCR assay described  elsewhere  (24).  Genomlc  DNA  (1 
p,g) was amphfied by PCR for 30 cycles (1 min at 95~  2 mm at 
68~  and 5 rmn at 72~  in 50 ILl reaction buffer (Perkln-Elmer 
Cetus, Norwalk, CT.)  containing 1.25 U  AmphTaq polymerase 
(Perkin-Elmer Cetus)  and 1 ~M each of 5' and 3' primers.  The 
pnmers used to detect D[32 toJI32 rearrangements  were as follows: 
5'D[32,  5'-GGAGGGGGACTAGCAGGGAGG-3'; and  3'J[3_,, 
5'-CACCCAGCTCCTCCAGCTCCGG-3'  For  V-D-J  rear- 
rangements,  VJ3-speclfic primers  (25) were used in concert with 
the 3' JI32 primer.  PCR products (16 ~zl) were electrophoresed, 
blotted onto nylon membranes (Zeta  Probe, Bio-Rad Laborato- 
nes, Hercules,  CA), and probed with a 32p-labeled 3'JI32 oligonu- 
cleotide  (5'-GGCTGGAAGGTGGGGAGACGCCCG-3')  lo- 
cated immediately 5' of the 3' Jj3o pnmer used for amphfication. 
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isolated  as  described  elsewhere  (18) were  run  on  1%  agarose- 
formaldehyde gels, trasferred  to nylon membranes,  and hybrid- 
ized as previously described (26) with 32p-labeled cDNA probes 
corresponding to the TCR Cot (PY1.4)  (27) or C]3 (Jur~2) (28) 
regions (kindly provided by Dr. T.W. Mak, The Ontario Cancer 
Institute.  Toronto, ON, Canada).  The human pT0t cDNA probe 
was derived in this study (see below). The same blot was subse- 
quently stripped  and hybridized with a [3-actin probe (26). 
Reverse Transctiptase-PCR Analysis.  Total  RNA  (1  btg) was 
reverse  transcribed  into cDNA according to the manufacturer's 
protocol (Boehringer Mannheim, Mannheim, Germany). Equiv- 
alent amounts of cDNA among different  samples was estimated 
by reverse transcriptase  (RT) PCR carried  out for 18, 21, and 25 
cycles with  [3-actin primers,  as previously described (18). Titra- 
tion of cycle number allowed us to perform densitometric analy- 
ses  (Bio-imaging BAS  1500;  Fujifilm,  Kanagawa,  Japan)  under 
nonsaturating conditions. The [3-actin control shown in Fig. 4 A 
also applies to PCR analyses shown in Figs. 4 B, and 5 A. Vot and 
VJ3 degenerate primers (29) used in combination with either Cot 
or  C[3  primers,  respectively,  enabled  the  amplification  of all 
known human Vot and V[3 segments,  as described (18, 29). V[3- 
specific  transcription  was  assessed by  using  VI32-, VI36-, and 
V1313.~-specific primers in concert with a C[3 primer, as previously 
reported (25). Specific amplifications  were detected by Southern 
blot hybridization with Cot (27) or C[3 (28) cDNA probes. 
Amplifications  ofpT0e cDNA were performed for 35 cycles, at 
an annealing temperature  of 55~  using the following primers: 
5'pTot, 5'-CCCATCTCTCCCTGCCTTCTG-3'; and 3'pTot, 
5'-GGAGCAGGTCAAACAGCAGC-3'.  Amplified  products 
were analyzed by Southern blotting with a cDNA pTot probe de- 
rived in this study (see below). RAG-1 transcription was assessed 
by RT-PCR carried  out for 30 cycles at an annealing tempera- 
ture of 55~  followed by Southern blotting using an oligonucle- 
otide probe.  As control for the  sensitivity  of the RAG-1  RT- 
PCR assay, amplifications were performed simultaneously on serial 
dilutions of a plasmid  vector containing the R.AG-1 full-length 
cDNA  (30),  mixed  with  a fixed  quantity  of irrelevant  cDNA. 
Signal  intensity was quantitated  by densitometric  analyses (Bio- 
imaging BAS 1500,  Fujiftlm).  The following primers were used: 
5'RAG-l,  5'-CAGCGTTTTGCTGAGCTCCT-3'; 3'RAG-l, 
5'-CTAGGAGAAGCCCTCAATGC-3';  and RAG-1 probe, 5'- 
AAGTATAGGTATGAGGGAA-3'. 
Cloning of the Human p Tee cDNA.  cDNA derived from TCRot/ 
[3- CD4+CD8  + thymocytes was amplified  for 40 cycles at an an- 
nealing temperature  of 50~  by using a combination of primers 
recognizing  sequences  in  the  Ig-like  (5'-CCTGGCCTTGAC- 
AACCCTGTCTG-3')  and  in  the  transmembrane  (5'-GTG- 
GTGGCTGGAGGTGCTGGCC-3')  domains  of the  reported 
mouse pTot cDNA (13). Amplified products were then fraction- 
ated, blotted, and probed with an internal oligonucleotide  (5'-GCT- 
GCAGGTCAGGAGCACATCG-3') specific for the transmem- 
brane domain of the mouse pTot. A 380-bp hybridizing product 
was purified by standard  procedures, cloned in a pMOS Blue-T 
vector (Amersham International, Amersham, Bucks, UK), and se- 
quenced  using  a  T7  DNA  polymerase  (Sequenase  II,  United 
States Biochemical Corp., Cleveland, OH). Sequence analysis re- 
vealed an 82% homology with the corresponding fragment of the 
murine  pTa  cDNA. The  cloned fragment was  then  used  as a 
probe for Northern blot and RT-PCR analyses  (see above), as 
well as to probe a cDNA human thymus library  (Clontech, Palo 
Alto,  CA.).  Three independent  positive clones out of 2  ￿  10  s 
plated clones  were isolated  by replating  and amplified  by PCR 
using two kgt11 primers flanking  the EcoRl cloning site. PCR 
reactions  were carried  out for 30 cycles at an annealing tempera- 
ture  of 55~  and  amplification  products were  cloned and  se- 
quenced as described  above. 
Immunoprecipitation and Western Blot.  7  ￿  107 Cells were lysed 
in 1 mt of lysis buffer (2% Triton X-100 [Sigma], 20 mM Tris- 
HCI, pH 7.6,  150 mM NaC1,  1 mM MgCI2,  10 mM iodoaceta- 
mide [Merck, Darmstadt,  Germany], 1 mM PMSF, and 1 ~g/ml 
each ofleupeptin, pepstatin, and aprotimn [Sigma Chemical Co.]). 
After removal of their nuclei,  supernatants  were precleared three 
times  with  normal  mouse serum  (NMS)  Igs coupled to  either 
protein A- or protein G-Sepharose beads  (Pharmacia  LKB).  Im- 
munoprecipitation  was  carried  out  overnight  with  [3F1 (anti- 
TCR[3)  (23) and otF1 (anti-TCR0c)  (T Cell Diagnostics,  Cam- 
bridge,  MA)  mAbs covalently coupled to either protein  G- or 
protein A-Sepharose beads,  respectively,  as described (31).  The 
precipitates  were separated  by SDS-12% PAGE under nonreduc- 
ing  conditions,  and  transferred  onto  nitrocelulose  membranes 
(Bio-Rad Laboratories).  Blots  were blocked with 5% skim milk 
TBS, and the TCR~ and TCR0t precipitates  were detected by 
hybridization with either J3F1 ascites diluted 1:2,000 (23), or with 
2.5 ~g/ml otF1 mAb, respectively.  After three washes with 0.2% 
Tween-20 (Sigma Chemical Co.) TBS blots were incubated with 
goat anti-mouse Igs coupled to peroxidase  (Amersham Interna- 
tional),  washed four times,  and revealed by the enhanced chemi- 
luminescence method (ECL; Amersham International). 
Results 
Characterization  of a  TCR-negative  subset  of CD4+ CD8 + 
Large Cycling Human  Thymocytes.  Recent  studies  have 
shown  that  the  differentiation  of the  the  most immature 
human  T  cell  precursors,  identified  as  CD34  +  DN  thy- 
mocytes (32),  proceeds throughout several TCR-negative 
stages  characterized  by the  progressive  loss  of CD34  and 
the sequential acquisition ofCD1, CD4, and CD8 (32-34). 
Thus,  human T  cell precursors  acquire  CD4 before  CD8 
(22, 34) as proposed in the following maturation sequence: 
CD34+CD1-CD4-CD8---)  CD34+CD1+CD4-CD8---) 
CD34+/-CD1 +CD4+CD8 ---)  CD34-CD1 +CD4+CD8 +. 
The latter subset seems to include the immediate progeni- 
tors  of the  major intrathymic  subpopulation  of small  DP 
thymocytes that  express  the  TCRcl/[3  complex and  then 
differentiate to the SP stage (17). 
To  identify  the  developmental  stage  at  which  the  suc- 
cessful expression of TCR[3 may be of selective advantage 
to human thymocytes independent of the TCRot chain, we 
examined [3 and ot chain gene status in individual subsets of 
TCRet/[3-  early T  cell progenitors isolated from the post- 
natal  thymus,  according  to  the  proposed  maturation  se- 
quence (17). To this end, large thymocytes recovered from 
Percoll gradients  were  depleted  of mature T, B,  NK,  and 
myeloid cells.  As  shown  in  Fig.  1 A,  expression  of CD4 
and CD8 defined three  different subsets  of TCR-negative 
thymocytes  within  the  remaining  pool:  CD4-CD8-, 
CD4+CD8 -,  and  CD4+CD8 +, representing  9.5  +  4.5%, 
29  +  10%,  and 60  +  10%, respectively. Immunomagnetic 
sorting allowed the independent isolation of the three sub- 
sets that showed a >99% purity upon reanalysis (Fig.  1 A). 
By forward scatter (FSC) analysis, each TCR-negative sub- 
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Figure 1.  Cell  surface pheno- 
type of individual  subsets of large 
TCR-  human thymocytes. (/t) 
CD4  vs.  CD8  expression on 
Percoll-separated  large TCR- 
thymocytes  defines  three dis- 
tinct  subsets  of  CD4-CD8-, 
CD4+CD8  -,  and  CD4+CD8  + 
thymocytes. Each subset was re- 
analyzed for CD4 vs.  CD8  ex- 
pression after inununomagnetic 
sorting. (B) Expression of CD34 
vs. CD1 in the C1)4-CD8- pop- 
ulation shown in A defines two 
subsets  of  CD34+CD1  +  and 
CD34+CDI  thymocytes.  Rep- 
resentative profiles of CD34 vs. 
CDI expression  on both isolated 
subsets are shown. (C) Expression 
of  TCRo~/~, CD813, CD28, 
CD44,  and  CD71  on  either 
TCR0dl3-  CD4+CD8  +  large 
thymocytes shown in A  (shaded 
areas), or TCRc~/[3  § CD4+CD8  + 
small thymocytes separated on 
Percoll gradients (unshaded areas). 
(Dashed histograms) Background 
values  obtained with isotype- 
matched irrelevant  mAbs. 
set  was  shown  to  include  relatively  large-sized  cells,  as 
compared with the subset of conventional TCRot/[3 + DP 
cortical  thymocytes  isolated  from  the  Percoll  fraction  of 
small  cells  (Table  1).  As  expected  (32),  nearly  all  cells 
within the CD4-CD8-  pool express CD34, whereas CD1 
defines two distinct subpopulations of CD34+CD1 + (52.5  + 
6%)  and CD34+CD1 -  (47.5  -+  6%)  thymocytes that were 
independently isolated  (>99% pure)  by immunomagnetic 
sorting (Fig. i  B). Based on the expression ofCD34, CD1, 
CD4,  and  CD8  molecules,  the  four  isolated  subsets  of 
TCR-negative large-sized thymocytes will be hereafter re- 
Table 1.  Forward  Scatter and Cell Cycle Analysis of Early Human 
Thymocyte Subsets 
Subset 
Mean  Percent  Percent total 
FSC  cycling  thymocytes 
+  SD  cells •  SD  -+ SD 
CD4-CD8-TCRot/[3-  439  -+ 20  11.0 •  1.5  0.69  -+ 0.3 
CD4+CD8-TCRo~/[3  -  404 •  24  10.5 •  3.6  2.21 •  1.3 
CD4+CD8+TCRa/[3  -  422 •  12  42.0  •  4.5  6.57  •  4.3 
DP TCRa/[3 +  311  +  3  2.2 •  0.9  10.10 •  4.5 
Postnatal thymocytes were fractionated into populations enriched for 
large or small cells on Percoll density gradients. Subsets of TCRe~/[3 
thymocytes and TCR0~/[3  + DP thymocytes were purified either from 
the large or from the small cell fractions, respectively. Medium-sized 
cells including both SP and DP TCRoW~3  + thymocytes were not ana- 
lyzed in this study. 
ferred  to  as  CD34+CD1 -,  CD34+CD1 +,  CD4+CD8 -, 
and CD4+CD8 +. 
We next examined in more detail the phenotypic profile 
displayed by TCRc~/[3- CD4+CD8 + large thymocytes, as 
compared  with  that  of  common  cortical  TCR~x/[3 + 
CD4+CD8 + small thymocytes (Fig.  1 C). It is notable that 
both subsets coexpressed CDScx and CD813  (Fig.  1 C) and 
displayed  similar  expression  levels  of CD1,  CD2,  CD4, 
CD5, and CD7 T-lineage molecules, whereas both lacked 
expression of CDllb, CD13, CD14, CD16, CD25, CD33, 
CD56, and CD69 (not shown). However, markers such as 
CD28, CD44, and CD71  (transferrin receptor), which were 
weakly  expressed  on  small  TCR~/[~  +  CD4+CD8 +  thy- 
mocytes, were consistently found at higher expression levels 
on large  TCRot/[3-  CD4+CD8 +  thymocytes  (Fig.  1  C). 
More importantly, both subsets were shown to differ dra- 
matically in their cell cycle status. As shown in Table 1, the 
proportion  of  TCRcx/[3-  CD4+CD8 +  thymocytes  en- 
gaged in DNA synthesis and mitosis (up to 45%) was much 
higher than the proportion of the TCRod[3 + CD4+CD8 + 
pool  (up to  3%),  or any other subset of thymocytes (up 
to  12%).  To  avoid  confusion,  conventional TCRot/[3 + 
CD4+CD8 + small thymocytes will be hereafter referred to 
as DP thymocytes. 
TCRfl  Chain  Gene  Rearrangement  during  Human  Thy- 
mocyte Development.  Each individual subset of TCR&/~- 
thymocytes was next examined for the rearrangenient sta- 
tus of their TCR~3 loci by using a PCR genomic assay (24). 
As shown schematically in Fig. 2 A, the combination of a 
primer located immediatly 5'  to  D[32 with a primer posi- 
tioned 3' to the JI3z cluster, allowed us to detect amplifica- 
tions of a gernfline fragment, as well as of a set of smaller 
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to each of the seven J[32 (J[~2.l-J[32.7)  gene segments (35). As 
expected  from the physical map,  V[3-specific primers  (25) 
used in combination with the 3][32 primer enabled the am- 
plification  of complete  V-D-J  rearrangements,  but  not  of 
germline fragments (35). The resulting PCR products were 
analyzed by  Southern  blot  hybridization  with  an  internal 
primer positioned immediately 3' to the J[32 duster (Fig. 2 A). 
Partial  rearrangements  of D[32  to J[32 were  consistently 
negative  in  the  most  early  CD34+CD1 -  thymocytes,  in 
which a sharp germline band equivalent to that detected in 
non-T (K562) cells  was observed (Fig. 2 B). A  conspicuous 
germline  amplification product was also readily detectable 
in  the  two  downstream  subsets  of  CD34+CD1 +  and 
CD4+CD8 -  thymocytes, indicating that they were  essen- 
tially in germline configuration. However, very faint bands 
of  rearrangement,  particularly  those  corresponding  to 
short-sized products whose amplification is favored by this 
technique,  were  eventually  detected  in both  subsets  upon 
prolonged  exposure.  In  contrast,  multiple  rearrangements 
of D[32  to  the J[32.1-J[32.7  elements,  as  extensive  as  those 
found in TCRet/[3 + (DP or SP) thymocytes, were detected 
at the next developmental stage ofTCRcl/[3- CD4+CD8 + 
large thymocytes (Fig. 2/3). Rearrangements involving V[3 
segments  were  essentially  negative  at  both  the  CD34  + 
CD1-  and the  CD34+CD1 +  developmental  stages.  Weak 
bands  corresponding  to  complete  V-D-J  rearrangements 
were  first  detected  at  the  CD4+CD8 -  stage.  In  contrast, 
the  TCRo~/[3-  CD4+CD8 §  large  thymocytes displayed  a 
pattern  of multiple  rearrangements similar to that observed 
in  more  mature  TCRot/i3-expressing  thymocytes.  As  an 
example,  the V[33-J[32 rearrangement patterns  observed are 
shown in Fig. 2  C. Identical results were obtained for rear- 
rangements involving V[3~, V[39, and V[319 genes (not shown). 
Timing of TCR~ and TCRoe Gene Transcription during Hu- 
man Thymic Development.  To next examine the transcrip- 
tional activation  of TCRix  and TCR[3  genes during  early 
thymocyte development,  total RNA isolated from each in- 
dividual  TCR-negative  subset  was  analyzed by Northern 
blotting.  As  shown  in  Fig.  3,  hybridization  with  a  C[3 
probe  revealed  that  TCRoe/[3-  CD4+CD8 §  large  thy- 
mocytes displayed a pattern of abundant  1.3-kb mature and 
1.0-kb  immature  TCR[3  transcripts  that  resembled  that 
found in more mature  DP  or SP  TCRcx/[3 +  thymocytes. 
In contrast, mature transcripts were weakly detected in their 
immediate  precursors  (i.e.,  CD4+CD8 -  TCRcx/[3-  thy- 
mocytes) and were absent in the most early CD34+CD1 - 
and  CD34+CD1 §  thymocytes.  All  these  subsets,  however, 
expressed  1.0-kb immature TCR[3 transcripts  (Fig. 3),  and 
Figure 2.  Analysis  of D-J and V-D-J TCR[3 gene rearrangements dur- 
ing human thymocyte development. (/I) Schematic representation of the 
DNA-PCR strategy showing the positions of the primers used either for 
amplification (arrows) or for hybridization (solid bar) of DIB2-JJ32 and V~3- 
D]32-JJ32 rearrangements. (B) Southern blot analysis ofD~32-J~32  rearrange- 
ments in the indicated thymocyte subsets. (C) Southern blot analysis of 
V~3-D~2-J~ 2 rearrangements in DNA samples identical to those shown 
in B. Total thymocytes (T Thy) and K562 cells served as positive and neg- 
ative controls, respectively. (Right) Positions of  the germline fragment and 
the specific rearrangements of DIB2 (B) or V!B  3 (C) to the J~2.i-J~2.7  ele- 
ments. 
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Figure 3.  Regulation  of TCRiB, TCRcx, and pToe gene transcription 
during human thymic development. Northern blots of total RNA iso- 
lated from the indicated cell sources were hybridized with  TCR-CiB, 
TCR-Cot,  or pTot cDNA probes, iB-actin mRNA expression served as 
internal control. Sizes of  the bands are indicated at the right (Kb). Figure 5.  Regulation of RAG-I expression during human intrathymic 
development.  (A) RAG-I  trancription was  assessed by RT-PCR  and 
Southern blotting in the indicated cell samples. Sizes of amplified prod- 
ucts are indicated at the right (bp). The [3-actin control is shown in Fig. 4 
A. (/3) The relative intensity values of amplifications  corresponding to a 
RAG-1  cDNA titration curve (top) were plotted against the number of 
RAG-I cDNA molecules in a logarithmic scale (bottom). 
Figure 4.  RT-PCR analysis of TCR[3 and TCR{~ gene transcription 
in early human thymocyte subsets. (A) cDNA samples  prepared from the 
indicated cell  sources were amplified by using pan-V[3 and pan-Vet prim- 
ers in concert with C[3- or C{x-specific  primers, respectively. Amplified 
products were  analyzed by Southern  blotting  with  either  C[3  or  C{x 
cDNA  probes. Equivalence of cDNA among different samples was as- 
sessed by RT-PCR using [3-actin  primers under nonsaturating conditions 
(21  and 25 cycles). Sizes of amplified products are indicated at the right 
(bp). (/3) Expression of full-length TCRI3  transcripts was  analyzed by 
RT-PCR using V[32-, V[B6-, and V[3131-specific  primers in concert with a 
C[3 primer,  cDNA  samples and [3-actin controls are identical to  those 
shown in A. 
low levels of 1.6-kb germline transcripts could also be de- 
tected upon  prolonged exposure  (not shown).  Subsequent 
hybridization with  a  Cot  probe  showed  that  expression of 
1.6-kb  mature-length  TCRot  transcripts only occurred  in 
the DP  or SP stages, at which the TCROt/[~  is already ex- 
pressed  on  the  cell  surface  (Fig.  3).  Expectedly,  mature 
TCROt  and  TCR[3  transcripts  were  present  in Jurkat  T 
cells, but not in JY B  cells. 
To  ascertain  unambiguously  the  expression  of mature 
TCR~  message at the CD4+CD8 -  stage, as well as to con- 
fima the lack of TCRot transcription in both the CD4+CD8 - 
and  the  CD4+CD8 +  subsets,  further  studies  were  per- 
formed by using  a  sensitive RT-PCR  technique  (18,  29) 
proved  to  detect  transcription  of all known  V[3  and  Vot 
TCR  genes.  As  shown  in  Fig.  4  A,  the  combination  of 
panV[3  primers  with  C[3  primers  revealed  that  TCROt/[3- 
CD4+CD8 -  thymocytes had readily detectable amounts  of 
TCR[3 message. There was a higher expression in TCROt/[3- 
CD4+CD8 +  blasts,  whereas  no  amplified  fragments  were 
detected  in  CD34+CD1 -  and  CD34+CD1 +  thymocytes. 
Expression  of V-D-J-C[3  transcripts  at  the  CD4+CD8 
stage was independently confirmed by using C[3 primers in 
combination with V~-specific primers (25). Representative 
results  corresponding  to  V[32-,  V[36-,  and  V[313-specific 
amplifcations are shown  in Fig. 4  B.  In addition, pan-Vet 
primers  used  in  combination with  Cot  primers  confirmed 
the  absence  of TCR{x  transcripts in  all thymocyte subsets 
shown  to  lack  surface  TCRet/[3  (Fig.  4  A).  Collectively, 
our  data  suggest  that,  in  contrast  to  mice,  the  onset  of 
V-D-J TCR[~ gene rearrangement and transcription occurs 
in  humans  in  immature  thymocytes  already  expressing 
CD4,  and is essentially completed during the  transition to 
the next TCROt/[3-  CD4+CD8 + developmental stage. 
RAG-I  Gene Transcription  Is Intrathymically  Upregulated  dur- 
ing the Transition from the CD34+ CD1 -  to the CD34+ CD1 + 
Stage.  Previous studies in  mice have  shown  that  the  ex- 
pression  of RAG-1  and  RAG-2  genes  usefully traces  the 
emergence  of TCR  gene  rearrangement  and transcription 
during T  cell development (36).  To  approach this issue in 
humans,  RAG-1  transcription was  analyzed by RT-PCR 
in  the  thymocyte  subsets  previously  examined  for  their 
TCRI3  and  TCROt  gene  status  (Fig.  5  A).  Comparative 
524  Human Pre-TCR Gene Expression -23  -1 
h  GCPA 
H LL H E  WAMA  RTWL L L L LGV RC QA 
~i  "~  x7  so 
h ~l~T~V  G~  T  P  F  P  S  L  A  PP  INFC-~K~Q~V~-C~~I~ 
mL[~S~I A~G ~P F  P  S  LAPP  IITLJ._~(.~_~R~]~LW  V  C  L  V  L  ~A P  P  G  L  D~]VlW  F  S  A  Q 
h~GSALDAFTYGPN  S  G~-~E~H 
IIWGSA  L  DA  F  TY GP ~L~PDGTIVnSL~]OL  SL P  S  E  E  LE Am E  P  L  V  CHIIR[P  GAJG~IQ 
101  ~'  ~"~-I********  ~  ****~,,,lSO 
h  H  R  GGA  GV  F  L 
151,  I  .  c~,o=~==xe  M=  ~  ~  200 
h ~'T'~C D  PA  G  P  L  PS PA  T~RA~G~-'~A  T  E  T  G  G  R  EA~S~'P-~P  Q  P  R 
=LTCSI~J  ..............  BJ.JHVLJA  G  Q  H~P  P  R~_~S  L P  P~H  I W  T Z- - 
ZO1  ZSO 
b DRRWGDTPPGRKPGSPVWGEGSYLSSYPTCPAQAWCSRSRLRAPSSSLGA 
II ................................................. 
251  ~  Z6S 
b. FFAGDLPPPLQAGAA 
=  ............... 
Figure  6.  Predicted human  pTet amino  acid sequence. Comparison 
and alignment of the predicted amino acid sequence of human pTc~ with 
the  corresponding murine pTtx sequence is shown. (Boxed) Conserved 
residues; (dashes)  gaps at the cytoplasmic  tail. (V) The three cysteines  con- 
served in positions 31, 91, and 119. Locations of the potential N-linked 
glycosilation sites (CHO) and protein kinase C  (PKC) phosphorylation 
sites are indicated. (V) Mismatches  with respect to a recently reported hu- 
man pTtx sequence (37). Amino acid sequence analysis  was done with the 
PROSITE  pattern  database (45). The nucleotide sequence data of the 
cloned human pTa cDNA are available from EMBL/GenBank/DDBJ, 
under accession  number U38996. 
densitometric analyses were performed by using a  RAG-1 
cDNA titration curve (Fig. 5  B). As shown in Fig. 5 A, ex- 
pression of RAG-1  was  hardly detected in  the  most  early 
CD34+CD1  thymocytes,  but  it  increased  abruptly 
(~'-'500-fold)  at  the  next  CD34+CD1 +  and  CD4+CD8 
developmental stages.  A  slightly weaker  (about  threefold) 
expression  was  found  in  TCRcx/[3-  CD4+CD8 +  blasts. 
However,  the  amount  of RAG-1  message increased again 
(about  20-fold)  in  the  more  mature  TCRcl/[3 +  DP  small 
thymocytes, coincident with the onset of TCRo~  trancrip- 
tion,  whereas  no  message  was  detected in  SP  thymocytes 
(Fig.  5  A).  Because  of the  high  sensitivity of the  RAG-1 
PCR  assay that allowed us to detect as few as 15 transcripts 
(Fig.  5  B),  it  is  very  likely  that  the  signal  displayed by 
CD34+CD1 -  thymocytes (corresponding to  ~<75  RAG-1 
cDNA molecules) may reflect the amplification of RAG-1 
transcripts  present  in  a  minute  contaminating  subset  of 
CD1 +  cells. These  data suggest that  transcriptional activa- 
tion  of  RAG-1  begins  during  the  transition  from 
CD34+CD1-  to CD34+CD1 + thymocytes, slightly before 
the onset of TCR[3  rearrangement,  and is shut down after 
TCRo~ expression in cells in transit to the SP stage. 
Cloning  and  Developmental  Expression  of  the  Human 
pTce Gene.  The  identification of a  subset  of TCRe~/[3- 
CD4+CD8 + cycling thymocytes that express mature TCR[3 
message, although lacking TCRcx  transcripts, prompted us 
to search for the possible expression in these cells of a gene 
homologous to the murine pTe~ (13).  cDNA derived from 
TCRe~/[3-  CD4+CD8 +  blasts  allowed  us  to  clone  a  hu- 
man  cDNA  fragment  spanning  985  nucleotides  that  en- 
codes  a  protein  with  87%  amino  acid identity to  murine 
pT(x  at  the  extracellular and  transmembrane  domains,  but 
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Figure 7.  Regulation of pTot gene expression in human T cell ontog- 
eny. pTe~ mRNA expression was analyzed by RT-PCR and Southern 
blotting in CD34 + precursors isolated from fetal liver (FL), fetal bone 
marrow (FBM), adult bone marrow (ABM), mobilized peripheral blood 
(PB), or cord  blood (CB). CD34§  thymocytes and  unseparated 
thymocytes obtained from the adult (1-yr-old) thymus (A  7), as well as to- 
tal thymocytes from a 22-wk-old  fetal thymus (FT), were  included as 
positive controls. Omission of template cDNA (water)  served as negative 
control.  Integrity of cDNA samples was assessed by amplification with 
~-actin primers after 25 cycles. Sizes  of the PCR products are indicated at 
the right (bp). 
containing  a  longer  cytoplasmic  tail  (Fig.  6).  These  data 
were considered reasonable evidence that we had identified 
the gene encoding the human pT0t chain. In addition, after 
submission  of  this  manuscript,  another  group  indepen- 
dently cloned a human cDNA (37) with a predicted amino 
acid sequence essentially identical to that reported here, ex- 
cept for positions 64, 72,  147, and 253  (Fig. 6). 
Next, Northern blot analyses provided evidence that pTot 
transcription is tightly regulated during human T  cell develop- 
ment. As shown in Fig. 3, we found that the largest amount 
of pTet  transcripts  (1.2  kb)  corresponded  to  CD4+CD8 - 
and CD4+CD8 + TCRot/[3-  immature thymocytes. There 
was  a  weaker  expression  in  earlier  (CD34+CD1 -  and 
CD34+CD1 +)  and  later  (TCRcx/[3 +  DP)  developmental 
stages, whereas no pT(x transcription was detected in mature 
SP thymocytes. These results were confirmed by RT-PCR 
(not shown). 
Expression of murine  pTo~  has been  reported to be ex- 
quisitely T-lineage specific (38). Accordingly, we could not 
detect pT~x  transcription in  human  non-T  cells including 
B, NK, myeloid, and dendritic cells (not shown). To inves- 
tigate whether  pTol  transcription is specifically induced in 
early pro-T cells after homing to the thymus, expression of 
pTot mRNA  was examined by RT-PCR  in highly purified 
CD34 §  hematopoietic  progenitors from  distinct postnatal 
and  fetal  extrathymic  tissues.  Total  thymocytes  derived 
from either fetal (22-wk-old) or adult (1 mo-3 yr) thymus, 
as well as CD34+CD1 -  precursors from adult thymus were 
included in the study as positive controls. As shown in Fig. Figure  8.  TCPq3 chain expression in  TCP,~x/~- 
CD4+CD8 + large cycling thymocytes. (A)  Flow cy- 
tometry  analysis  of  TCRoe/J3-  CD4+CD8 -  and 
TCt<o~/[3- CD4+CD8 +  thymocytes tbr  cytoplasmic 
TCR~  (,8F1) expression (shaded histograms). (Unshaded 
histograms) Background fluorescence. (/3) Expression of 
an immature TCP,[3 complex distinct from the mature 
TCRe~/13  heterodimer  in  TCRa/i3  CD4+CD8 + 
blasts. Western  blots  of TCR[3 (~F1) and  TCIt.o~ 
(eeFl) immunoprecipitates from the indicated cell sam- 
pies were revealed with mAbs  to TCR~ or TCRoc re- 
spectively. Precipitations with  normal  mouse sernm 
(NMS) served as negative controls. Molecular sizes are 
indicated on the left (kDa). Bands corresponding to the 
intracellular and surface forms of the  TCR.oc/iB het- 
erodimer precipitated fromJurkat T cells (~'), as well as 
the position of the immature TCIk[3 complex precipi- 
tated  from  TCRel/iB  CD4+CD8 +  blasts ([>), are 
indicated. 
7,  transcription  of pTo~  was  easily  detected  in  mobilized 
CD34 +  cells from  peripheral blood,  as well as in  CD34 + 
precursors isolated from umbilical cord blood or from adult 
bone marrow. More importantly, pT(x gene expression also 
occurred in  fetal life in  CD34 +  progenitors present in the 
liver  at  18  wk  of  gestation,  although  it  was  absent  in 
CD34 + precursors from fetal bone marrow at any develop- 
mental  age  up  to  22  wk.  These  results  suggest  that  tran- 
scription of the pTcl gene is activated early in ontogeny in 
CD34 + progenitors, before their entry into the thymus. 
TCR~8  Chain Is Expressed  in CD4 +  CD8 + Blasts: Identifica- 
tion of an Immature  TCR~8  Complex Distinct fiom  the TCRee/13 
Heterodimer.  The  coincident  expression  of large amounts 
of TCR[3  and  pTor  transcripts in  TCRcl/13-  CD4+CD8 + 
blasts raised the  possibility that,  at this stage,  cells have  al- 
ready  been  selected  by  means  of a  putative  human  pre- 
TCR  complex consisting of a  functional TCR.~  chain as- 
sociated  with  the  pTo~  chain.  Flow  cytometric  analysis 
shown  in  Fig.  8  A  revealed that  cytoplasmic TCP, I3  was 
first expressed in  a  minor proportion  of CD4+CD8 -  thy- 
mocytes (5-10% in different experiments). Consistent with 
the prediction in mice of >56% for a population in which 
cells have been selected on  the basis of TCR[3  expression 
(39), cytoplasmic TCR[3 protein was found in most (80-90%) 
TCRcI/[3-  CD4+CD8 +  human  blasts  (Fig.  8  A).  There- 
fore, nearly all cells at the TCR(x/13- CD4+CD8 + stage have 
been selected based on productive 13 gene rearrangement. 
To characterize the molecular form of TCR[3  chains in- 
volved in this selection process, lysates from the TCR(x/[3- 
CD4+CD8 -  and CD4+CD8 +  thymocytes, as well as from 
the  TCRcx/[3-expressing Jurkat  T  cell line,  were  precipi- 
tated  with  mAbs  against  constant  regions  of  either  the 
TCR13  (13F1) or the TCRo~  (cxF1)  chains, and the  immu- 
noprecipitated proteins were then analyzed in Western im- 
munoblots  with  mAbs to  TCR~  or TCRci,  respectively. 
As  shown  in  Fig.  8  B,  the  anti-TCR[3  mAb  precipitated 
three  13  chain  monomeric  forms  (36-40  kD)  from  both 
thymocyte subsets as well as from Jurkat T  cells, although a 
very  faint  signal  was  observed  in  the  CD4+CD8 -  thy- 
mocytes (Fig. 8  B,  le/?). As expected from previous studies 
(40), two different bands corresponding in size to the intra- 
cellular (70  kD)  and the cell surface expressed (80-90  kD) 
TClLo~/[3  heterodimer were  detected  in  anti-TCR13  pre- 
cipitates from Jurkat  T  cells, but  were  absent in  both  the 
CD4+CD8  and  the  CD4+CD8 +  thymocyte  subsets.  In 
contrast, a single band, with a slightly lower molecular mass 
than  the  70-kD  intracellular TCRo~/[3  heterodimer,  was 
detected  in  TCR13  precipitates  from  CD4+CD8 +  thy- 
mocytes,  but  was  completely absent  in  CD4+CD8 -  thy- 
mocytes  (Fig.  8  B,  lf/?).  Strikingly, the  anti-TCRe~  mAb 
failed to  immunoprecipitate  this  TCR[3  complex,  or  any 
other  protein  complex,  from  CD4+CD8 +  thymocyte  ly- 
sates,  whereas  an  80-90  kD  TCRo~/[~  heterodimer  was 
precipitated from Jurkat T  cells with this reagent (Fig. 8  B, 
right  ).  Therefore,  our data provide evidence that TCRoc/13- 
CD4+CD8 +  blasts  express  an  immature  TCR13  complex 
composed  of  the  TCR[3  chain  associated  with  another 
chain  different from  TCR~.  Although the molecular mass 
of this complex fits with that expected for a  human  pTo~- 
TCR13  heterodimer,  direct evidence  for  this  notion  nmst 
526  Human Pre-TCP, Gene Expression still  await the  development  of suitable  reagents  against the 
human pTot chain. 
Discussion 
In this study, we have tried to identify the critical stages 
in  early human intrathymic  differentiation  where  most of 
the  developmental  decisions  are  made.  In  particular,  we 
have focussed on the developmental point at which TCRI3 
may confer on intrathymic precursors a selective advantage 
to  mature  further  in  the  absence  of TCRcx  expression. 
These studies  have been greatly facilitated by the  observa- 
tion  that  the  DN  to  DP  transition  occurs  in  humans 
through  a  CD4+CD8 -  intermediate  (32-34).  Our results 
show that it is precisely at this CD4+CD8 -  developmental 
stage  that  complete V-D-J[3 gene rearrangement  and full- 
length  TCR[3  transcription  are  first  detected,  although 
many of these cells  still  display a TCR[3 germline configu- 
ration. In contrast, extensive V-D-J[3 gene rearrangement and 
mature-length  TCR[3 message are common in TCRo~/[3- 
CD4+CD8 § thymocytes, known to represent the immedi- 
ate progeny of CD4+CD8 -  cells  (32-34). As predicted for 
a population in which cells  have been selected on the basis 
of successful [3 gene rearrangement (39), cytoplasmic TCR[3 
protein  was  found  in  nearly  all  TCRci/[3-  CD4+CD8 + 
thymocytes. These data allowed us to propose a model for 
the early stages of human intrathymic development (Fig. 9) 
that envisages the CD4+CD8 -  to CD4+CD8 + transition as 
the  critical point at which human thymocytes are selected 
based on productive TCR[3 expression.  According to this 
model, the onset ofV-D-J TCR[3 gene rearrangement and 
transcription occurs relatively late in human thymocyte de- 
velopment, as CD34+CD1 + pro-T cells downregulate CD34 
and  acquire  the  CD4  coreceptor molecule,  and  it  is pre- 
ceded  by  activation  of the  recombinase  machinery  (i.e., 
transcription  of  RAG-l)  during  the  CD34+CD1 -  to 
CD34+CD1 +  transition.  These  results  seem  in  conflict 
with those recently reported by Ktorza et al.  (41)  showing 
RAG-1 and mature TCR[3 transcription at earlier intrathy- 
mic  stages.  However,  no  quantitative  analyses  were  re- 
ported in that study to rule out the possibility that amplified 
transcripts do correspond to downstream cell contaminants. 
The proposal  that  productive  TCR[3  expression  occurs 
at  the  CD4+CD8 -  to  CD4+CD8 +  transition  is  further 
supported by our observation that TCRc~/~-  CD4+CD8 + 
thymocytes include  a  high proportion  of cycling cells,  an 
expected, finding considering that  functional  expression  of 
TCR[3 results in clonal expansion ofmurine thymocytes at 
the  equivalent  developmental  point  (5,  7,  8).  Based  on 
what is already known in the mouse about the implication 
of the  pToL-TCR[3  complex  in  this  maturation  step,  we 
performed  experiments  designed  to  provide  evidence  for 
the  existence  of an  equivalent  complex  in  humans.  We 
identified  and cloned a human cDNA highly homologous 
to  the  murine  pTci  (13),  with  a  predicted  anfino  acid se- 
quence that is essentially identical  to that recently reported 
by others  as  the  human  pTcl  chain  (37).  As  described  in 
mice (13), pTcx gene expression was also shown to be de- 
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Figure 9.  Proposed  model for the early T cell developmental stages in 
the human postnatal thymus. The figure summarizes the ordered progres- 
sion of early human T cell development, focusing on the expression of 
pTot and fully rearranged TCRI3 genes encoding a putative pre-TCR 
complex. Selection based on productive TCRi3 expression is placed at the 
transition between CD4+CD8  -  and CD4+CD8  + immature TCRo~/i3 
thymocytes. The model purposely mirrors the recently reviewed analyses 
of early T cell (3) and B cell (44) development in the adult mouse. 
velopmentally  regulated  in  humans.  We  found  that  pTor 
message is  highly expressed  by both the  CD4+CD8 -  and 
the  CD4+CD8 +  TCRod[3-  thymocyte  subsets,  whereas 
there is a weaker expression in earlier and later stages of de- 
velopment.  The  coincident  expression  of TCR[3  protein 
and  pTo~  transcripts  (in  the  absence  of TCRor  y,  and  8 
proteins)  in  TCRod[3-  CD4+CD8 +  blasts,  strongly  sug- 
gests  that  cells  in  transit  to  this  stage  monitor the  occur- 
rence  of productive TCR[3 rearrangements  through a hu- 
man pTcI-TCR[3 heterodimer.  Supporting this possibility, 
a TCR[3 complex of the expected size,  and different from 
the  mature  TCR~x/[3  heterodimer,  was  immunoprecipi- 
tated  from  TCRod[3-  CD4+CD8 +  blasts.  However,  we 
have been unable as yet to biochemically resolve this puta- 
tive  pTot-TCR[3  heterodimer  in  reducing  gels,  probably 
because the pTo~ chain escapes detection by current label- 
ing techniques, as reported in mice (12). Though pTci pro- 
tein  expression  studies  still  await the  development  of suit- 
able  anti-pTix  reagents,  the  results  reported  here  allow us 
to propose that the earliest direct action of the putative hu- 
man pre-TCR is to induce rapid clonal expansion,  and si- multaneous transition ofthymocytes from the CD4+CD8 - 
to the CD4+CD8 + stage. 
Analysis on the developmental expression  of the human 
pTcl  gene  provided  evidence  that  pToL is  also  expressed 
outside  the  thymus  in  CD34 +  progenitors  isolated  from 
distinct  adult  hematopoietic  tissues.  More  importantly, 
pTix  transcription  was  also  detected  early  in  fetal  life  in 
CD34 +  precursors  present  in  the  liver,  whereas  no  pTix 
expression  was found in fetal  bone  marrow  CD34 +  ceils. 
Although the precursor potential of the latter CD34 + sub- 
set needs to be analyzed before further conclusions can be 
drawn,  the  fact  that  CD34 +  fetal  liver  cells  do  contain 
TCIko~/[3  precursor  potential  (17,  18)  may  suggest  that 
there is a coincidence of pTot expression and precursor ac- 
tivity for TCP,.(x/~ T  cells in hematopoietic precursors be- 
fore their entry into the thymus. Alternatively, pTot-express- 
ing  extrathymic  CD34 +  cells  may  represent  recirculating 
pro-T  cells  derived  from the  thymus.  This  possibility  ap- 
pears  very unlikely  considering  that  pTot  gene  expression 
has also been found in the bone marrow of athymic mice 
(38).  Finally,  we  provide  evidence  that  pT(x  IkNA is  ex- 
pressed  by  the  most  immature  CD34+CD1 -  thymocytes 
that still  have the potential to develop into TCR~//8,  den- 
dritic, myeloid, and NK cells  (17, 21). Therefore, pTot tran- 
scription precedes  the  onset of TCP,[3  rearrangement  and 
IkAG-1 expression inside the thymus. An intriguing feature 
of these  early  intrathynfic  precursors,  also  found  in  their 
murine  counterparts  (2,  42),  is  that  they express  1.0-  and 
1.6-kb germline TCP,,13 transcripts before the onset of D-J 
TCR~  rearrangement  (our  present  study).  It  is  believed 
that TCR  gene segments are selectively rendered accessible 
to  the  recombinase  machinery  by  developmentally  regu- 
lated  transcription  while  they  are  still  in  their  germline 
configuration  (43).  Whether  the  coincident  expression  of 
pT(x  and  germline  TC1M3  transcripts  identifies  TCIt.ot/lB- 
committed precursors within  the  CD34+CD1 -  immature 
pool  of thymocytes  deserves  further  investigation.  How- 
ever, given that both the onset of full-length TCR.[3 tran- 
scription and the upregulation  of pTot gene expression are 
downstream events coincident with  the acquisition  of sur- 
face  CD4,  we  favor the  view that  the  CD4+CD8 -  stage 
represents  the critical point at which intrathymic precursors 
restrict their developmental potential towards the TCR(x/[3 
lineage. 
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